“TED is 5 times more prevalent in women, and because of that, men are often overlooked for the diagnosis,” Nijm said. The ...

Please provide your email address to receive an email when new articles are posted on . Thyroid eye disease treatments have evolved significantly in recent years. Work is still needed to find durable, ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

While argenx has been able to demonstrate the merit of its FcRn drug Vyvgart in multiple autoimmune indications, not every ...

Surgeries for thyroid eye disease include orbital decompression (to relieve swelling), strabismus (to repair eye muscles and correct eye alignment), and eyelid retraction correction (to restore eyelid ...

Percutaneous injection of triamcinolone improves margin reflex distance 1 (MRD1) and upper eyelid retraction (UER) in thyroid eye disease. "Percutaneous triamcinolone injection is an effective and ...

A data monitoring committee recommended stopping the phase 3 trials of efgartigimod in thyroid eye disease due to lack of efficacy.

Decompression and teprotumumab are effective for treating pediatric patients with thyroid eye disease (TED), according to a ...

Thyroid eye disease is a chronic condition that causes inflammation in your eyes. It affects about 25–50% of people with Graves’ disease, which is an autoimmune disorder that causes an overactive ...

Please provide your email address to receive an email when new articles are posted on . Teprotumumab-trbw has changed the landscape of thyroid eye disease management. Novel thyroid eye disease drugs ...